Blood Transfusion Diagnostics Market
Blood Transfusion Diagnostics Market By Product Type (Instruments, Kits & Reagents), By Application (Blood Grouping, Molecular Disease Screening), By End-user & By Region - Global Market Insights 2022-2032
Analysis of Blood Transfusion Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Blood Transfusion Diagnostics Market Outlook (2022-2032)
The global blood transfusion diagnostics market size was valued at US$ 4.42 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 7% from 2022-2032.
The increase in growth is due to this market's demand and economic expansion, Blood transfusion diagnostics refers to tests conducted on blood and blood components prior to transfusion to patients.
Report Attribute |
Details |
|
Anticipated Base Year Value (2021) |
US$ 4.42 Billion |
|
Expected Market Value (2022) |
US$ 4.73 Billion |
|
Projected Forecast Value (2032) |
US$ 8.7 Billion |
|
Global Growth Rate (2022-2032) |
7% CAGR |
|
Expected Market CAGR of the U.S. Market (2032) |
6.4% |
|
Anticipated Market CAGR of Europe (2022-2032) |
6.6% |
|
Major Blood Transfusion Diagnostic Service Providers |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Blood Transfusion Diagnostics from 2017-2021 Vs Market Projections for 2022 to 2032
For a few years, there has been an escalation in the demand for blood transfusions. This is due to an increase in the number of patients undergoing surgical procedures for chronic diseases such as aplastic anemia, sickle cell anemia, and leukemia. This has stimulated key players in blood banks and hospitals to concentrate on research and development for advanced instruments, assays, and kits.
The recent COVID-19 pandemic has provided opportunities for growth in the blood transfusion diagnostics market. In the United States, a series of plasma transfusion trials are being performed. The liquid medium is extracted from recovered patients and introduced to contaminated ones by practitioners.
This "convalescent plasma" is expected to enhance the immunity of cancer survivors. As a result of these trends, the global blood transfusion diagnostics market is anticipated to expand strongly during the forecast timeframe.
Which are Some Prominent Drivers of the Blood Transfusion Diagnostic Market?
Growing Demand for Blood and Blood Components to Generate Sales
The increasing prevalence of blood-related ailments such as hemophilia, cancer, thrombocytopenia, and others, as well as chronic kidney disease (CKD), has expanded the market for blood products and total blood transfusion.
Furthermore, the growing number of patients affected by anemia, which necessitates red blood cell transfusion for diagnosis, is predicted to push significant growth for blood transfusion diagnostics. As per World Health Organization (WHO) estimates, anemia affects approximately 1.62 billion individuals worldwide.
This, combined with increased awareness about blood safety from viral infections through various programs in both industrialized and developing countries, is driving up the consumption of blood screening tests and other diagnostic tools.
Transition to Automated Molecular Platforms to Boost Overall Growth
The adoption of innovative molecular platforms by leading companies accelerates the transition from manual tests and equipment to semi-automated and fully automated devices. These automated portals have been critical in sensing Transfusion Transmissible Infections (TTIs) in blood samples and can accurately eradicate human error during the transfusion procedure.
Thus, the introduction of such sophisticated automated systems has aided in the implementation of blood transfusion diagnostics and is anticipated to propel market expansion over the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Challenges Faced by the Blood Transfusion Diagnostic Market?
High Instrument Expenses and a Lack of Infrastructure are restricting Growth
Despite a growing prevalence of chronic blood diseases and increased requirements for blood products and transfusions, some aspects are impeding the market's expansion. One factor is insufficient investment in medical infrastructure and stringent regulatory policies, particularly in developing countries compared to industrialized nations.
Furthermore, the increased cost of tests, instruments, and reagents, combined with a lack of skilled employees to manage automated diagnostic solutions, is one of the aspects stifling the expansion of the blood transfusion diagnostics market over the coming years.
Comparative View of Adjacent Blood Transfusion Diagnostic Markets
Blood Transfusion Diagnostic Market :
|
Attributes |
Blood Transfusion Diagnostic Market |
|
CAGR (2022-2032) |
7% |
|
Market Value (2032) |
US$ 8.7 Billion |
|
Growth Factor |
The growing number of patients affected by anemia, which necessitates red blood cell transfusion for diagnosis, is predicted to push significant growth for blood transfusion diagnostics. |
|
Opportunity |
Growing demand for advanced technologies that can improve accuracy, pace, and cost-effectiveness is presumed to be the most critical growth aspect over the forecast period. |
Blood Cancer Diagnostics Market :
|
Attributes |
Blood Cancer Diagnostics Market |
|
CAGR (2022-2032) |
6% |
|
Market Value (2032) |
US$ 28.57 Billion |
|
Growth Factor |
Developing-nation Demand for Blood Cancer Diagnostics and burgeoning Leukemia prevalence to strengthen market growth prospects over the forecast period. |
|
Opportunity |
Favorable reimbursement regulations enacted to improve healthcare infrastructure will establish opportunities for expansion in the blood cancer diagnostics market in emerging nations. |
Which Regional Market is the Most Profitable for Blood Transfusion Diagnostic Manufacturers?
North America is set to maintain its position as the world leader in blood transfusion diagnostics. A high proportion of voluntary blood donors, as well as the integration of blood transfusion policies for safety and communicable disease testing, are critical growth factors. The North American market is projected to grow at a favorable CAGR of 6.4%, accounting for more than three-tenths of the overall market.
Asia-Pacific is predicted to grow the quickest, with a CAGR of 7.0%, accounting for more than two-fifths of the world's blood transfusion diagnostics market. This is due to the high incidence of TTIs in low-income countries, which generates higher demand for disease-screening techniques.
The existence of CE-approved instrument assays for serological and Nucleic Acid Test (NAT)-based practices in European countries is projected to propel in Europe.
Germany and the United Kingdom are major contributors to the European blood transfusion diagnostics market. The growing number of surgeries and transplantation methods can be attributed to the industry progress in these nations.
Transfusion procedures are tightly regulated in Germany. There are four kinds of organizations that provide blood services: state blood transfusion services, communal blood transfusion facilities, commercial blood centers, and plasmapheresis centers.
Country-wise Analysis
Why will the United States register high market revenue?
The high rate of surgical procedures for chronic illnesses is fueling growth
The United States is the largest contributor to the North American market. The growing number of surgical operations for chronic medical conditions is fueling the expansion of the blood transfusion diagnostics market in North America.
According to the American Red Cross Organization, 29,000 units of red blood cells, 5,000 units of platelets, and 6.500 units of plasma will be required daily in the United States by 2022. In the United States, 16 million blood components are transfused every year.
Orthopedic surgeries are among the most frequently performed operations in the world, as per data published by the American Academy of Orthopedic Surgeons in 2018. Thus, as the number of patients undertaking orthopedic surgeries grows, so does the demand for blood transfusion, bolstering the blood transfusion diagnostic market in the United States.
Which country in the Asia Pacific will dominate the regional market?
Emergence of an adequate healthcare service system to drive Market Growth
In 2022, China dominated the Asia Pacific blood transfusion diagnostics industry. The elevated usage of sophisticated technology in blood-related diagnoses, followed by a rise in the number of blood donation camps and blood banks in the nation, is credited to the market growth in China.
The country has enacted a blood donation law that permits voluntary unpaid blood donation, and donated blood can only be utilized for clinical practice. Despite disease outbreak constraints, China's National Health Commission registered 15.53 million blood donations in 2020.
As a result of the growing number of blood donations for clinical usage, there is a large market for blood transfusion diagnostics to monitor blood groups. Furthermore, swift economic growth allows for higher healthcare expenditures, allowing for the establishment of a decent healthcare service system through the use of technological innovations.
Country-wise Forecast CAGRs for the Blood Transfusion Diagnostic Industry
| Country | CAGR |
|
China |
6.9% |
|
U.S. |
6.4% |
|
Australia |
5.6% |
|
France |
5.9% |
Category-wise Insights
Which application segment will accelerate market growth?
Blood Grouping segment to Hold a Significant Position during the Forecast Period
During the projected period, the blood grouping segment will expand at a CAGR of 5.8%. The deployment of national blood transfusion regulations on blood typing and higher cost accessibility is expected to stimulate growth. During the forecast timeframe, the blood grouping segment is predicted to account for more than a quarter of the world's blood transfusion diagnostics market.
The blood grouping segment is forecast to expand as a consequence of the introduction of automated analyzers and growing preference for group typing and cross-matching tests before transfusion therapy to ensure donor and receiver blood sample adaptability.
Which Product Segment dominated the Market in 2021?
Kits & Reagents segment to witness demand due to Cost-Effectiveness
The global market is divided into two sections among products: instruments and, Kits & Reagents. Subjected to repeated sales of these products required for screening and blood group typing both donor and receiver samples, the Kits & Reagents segment accounted for the largest share in 2021.
Because of the higher cost and longer shelf existence of these instruments, the instruments segment accounted for a relatively low share in 2021. The Kits & Reagents segment is expected to grow rapidly during the projected timeframe.
Market Competition
Grifols S.A., Bio-Rad Laboratories, Inc., Immucor, Inc., CSL Ltd., Abbott Laboratories, F. Hoffmann-La Roche Ltd, QUOTIENT, Merck KGaA, and DiaSorin S.p.A. are the leading market players in the global blood transfusion diagnostics market. These market participants are focused on implementing technological breakthroughs in testing procedures. Plasma fractionation is an example of such technological advancement.
- In October 2019, Ortho Clinical Diagnostics declared FDA approval for the usage of Ortho Sera on its VISION analyzer.
- EryPharm entered the market in April 2021 with an advanced technology that can produce red blood cells in large quantities and build innovative blood transfusion sources.
- F. Hoffmann-La Roche Ltd and Bio-Rad Laboratories, Inc. signed a global partnership agreement in March 2021 to provide customers with access to Bio-full Rad's line of InteliQ products and Unity QC data management solutions.
Key Segments Profiled in the Blood Transfusion Diagnostic Industry Survey
-
By Product Type :
- Instruments
- Kits & Reagents
-
By Application :
- Blood Grouping
- Disease Screening
- Molecular Disease Screening
- Serological Disease Screening
-
By End User :
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Plasma Fractionation Companies
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Market 4. Market Overview 4.1. Introduction 4.1.1. Product Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Market Analysis and Forecasts, 2022-2032 4.4.1. Market Revenue Projections (US$ Mn) 4.5. Porter’s Five Force Analysis 5. Spend for Plasma Testing For Infectious Diseases (US$ Mn), by Plasma Fractionation Companies, 2022 6. Global Market Analysis and Forecasts, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2022-2032 6.3.1. Instruments 6.3.2. Kits & Reagents 6.4. Market Attractiveness, by Product Type 7. Global Market Analysis and Forecasts, by Application 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Application, 2022-2032 7.3.1. Blood Grouping 7.3.2. Disease Screening 7.3.2.1. Serological Disease Screening 7.3.2.2. Molecular Disease Screening 7.4. Market Attractiveness, by Application 8. Global Market Analysis and Forecasts, by End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2022-2032 8.3.1. Hospitals 8.3.2. Blood Banks 8.3.3. Diagnostic Laboratories 8.3.4. Plasma Fractionation Companies 8.3.5. Others 8.4. Market Attractiveness, by End-user 9. Global Market Analysis and Forecasts, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness, by Region 10. North America Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product Type, 2022-2032 10.2.1. Instruments 10.2.2. Kits & Reagents 10.3. Market Value Forecast, by Application, 2022-2032 10.3.1. Blood Grouping 10.3.2. Disease Screening 10.3.2.1. Serological Disease Screening 10.3.2.2. Molecular Disease Screening 10.4. Market Value Forecast, by End-user, 2022-2032 10.4.1. Hospitals 10.4.2. Blood Banks 10.4.3. Diagnostic Laboratories 10.4.4. Plasma Fractionation Companies 10.4.5. Others 10.5. Market Value Forecast, by Country, 2022-2032 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Product Type 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country 11. Europe Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product Type, 2022-2032 11.2.1. Instruments 11.2.2. Kits & Reagents 11.3. Market Value Forecast, by Application, 2022-2032 11.3.1. Blood Grouping 11.3.2. Disease Screening 11.3.2.1. Serological Disease Screening 11.3.2.2. Molecular Disease Screening 11.4. Market Value Forecast, by End-user, 2022-2032 11.4.1. Hospitals 11.4.2. Blood Banks 11.4.3. Diagnostic Laboratories 11.4.4. Plasma Fractionation Companies 11.4.5. Others 11.5. Market Value Forecast, by Country/Sub-region, 2022-2032 11.5.1. Germany 11.5.2. U.K. 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Product Type 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product Type, 2022-2032 12.2.1. Instruments 12.2.2. Kits & Reagents 12.3. Market Value Forecast, by Application, 2022-2032 12.3.1. Blood Grouping 12.3.2. Disease Screening 12.3.2.1. Serological Disease Screening 12.3.2.2. Molecular Disease Screening 12.4. Market Value Forecast, by End-user, 2022-2032 12.4.1. Hospitals 12.4.2. Blood Banks 12.4.3. Diagnostic Laboratories 12.4.4. Plasma Fractionation Companies 12.4.5. Others 12.5. Market Value Forecast, by Country/Sub-region, 2022-2032 12.5.1. China 12.5.2. Japan 12.5.3. India 12.5.4. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Product Type 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product Type, 2022-2032 13.2.1. Instruments 13.2.2. Kits & Reagents 13.3. Market Value Forecast, by Application, 2022-2032 13.3.1. Blood Grouping 13.3.2. Disease Screening 13.3.2.1. Serological Disease Screening 13.3.2.2. Molecular Disease Screening 13.4. Market Value Forecast, by End-user, 2022-2032 13.4.1. Hospitals 13.4.2. Blood Banks 13.4.3. Diagnostic Laboratories 13.4.4. Plasma Fractionation Companies 13.4.5. Others 13.5. Market Value Forecast, by Country/Sub-region, 2022-2032 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Product Type 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Product Type, 2022-2032 14.2.1. Instruments 14.2.2. Kits & Reagents 14.3. Market Value Forecast, by Application, 2022-2032 14.3.1. Blood Grouping 14.3.2. Disease Screening 14.3.2.1. Serological Disease Screening 14.3.2.2. Molecular Disease Screening 14.4. Market Value Forecast, by End-user, 2022-2032 14.4.1. Hospitals 14.4.2. Blood Banks 14.4.3. Diagnostic Laboratories 14.4.4. Plasma Fractionation Companies 14.4.5. Others 14.5. Market Value Forecast, by Country/Sub-region, 2022-2032 14.5.1. Saudi Arabia 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Product Type 14.6.2. By Application 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Company Profiles 15.1. Market Player - Competition Matrix (By Tier and Size of companies) 15.2. Market Share Analysis, by Company, 2020 (estimated) 15.3. Company Profiles 15.3.1. Grifols S.A. 15.3.1.1. Company Details 15.3.1.2. Business Overview 15.3.1.3. Financial Overview 15.3.1.4. Strategic Overview 15.3.1.5. SWOT Analysis 15.3.2. Immucor, Inc. 15.3.2.1. Company Details 15.3.2.2. Business Overview 15.3.2.3. Financial Overview 15.3.2.4. Strategic Overview 15.3.2.5. SWOT Analysis 15.3.3. Ortho Clinical Diagnostics 15.3.3.1. Company Details 15.3.3.2. Business Overview 15.3.3.3. Financial Overview 15.3.3.4. Strategic Overview 15.3.3.5. SWOT Analysis 15.3.4. Abbott 15.3.4.1. Company Details 15.3.4.2. Business Overview 15.3.4.3. Financial Overview 15.3.4.4. Strategic Overview 15.3.4.5. SWOT Analysis 15.3.5. Bio-Rad Laboratories, Inc. 15.3.5.1. Company Details 15.3.5.2. Business Overview 15.3.5.3. Financial Overview 15.3.5.4. Strategic Overview 15.3.5.5. SWOT Analysis 15.3.6. F. Hoffman-La Roche Ltd. 15.3.6.1. Company Details 15.3.6.2. Business Overview 15.3.6.3. Financial Overview 15.3.6.4. Strategic Overview 15.3.6.5. SWOT Analysis 15.3.7. QUOTIENT LIMITED 15.3.7.1. Company Details 15.3.7.2. Business Overview 15.3.7.3. Financial Overview 15.3.7.4. Strategic Overview 15.3.7.5. SWOT Analysis 15.3.8. BAG Healthcare GmBH 15.3.8.1. Company Details 15.3.8.2. Business Overview 15.3.8.3. Financial Overview 15.3.8.4. Strategic Overview 15.3.8.5. SWOT Analysis 15.3.9. DiaSorin S.p.A. 15.3.9.1. Company Details 15.3.9.2. Business Overview 15.3.9.3. Financial Overview 15.3.9.4. Strategic Overview 15.3.9.5. SWOT Analysis 15.3.10. Hologic, Inc. 15.3.10.1. Company Details 15.3.10.2. Business Overview 15.3.10.3. Financial Overview 15.3.10.4. Strategic Overview 15.3.10.5. SWOT Analysis
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 02: Global Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 03: Global Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 04: Global Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
Table 05: Global Market Revenue (US$ Mn) Forecast, by Region, 2022-2032
Table 06: North America Market Revenue (US$ Mn) Forecast, by Country, 2022-2032
Table 07: North America Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 08: North America Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 09: North America Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 10: North America Market Revenue (US$ Mn) Forecast, by End User, 2022-2032
Table 11: Europe Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 12: Europe Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 13: Europe Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 14: Europe Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 15: Europe Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
Table 16: Asia Pacific Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 17: Asia Pacific Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 18: Asia Pacific Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 19: Asia Pacific Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 20: Asia Pacific Market Revenue (US$ Mn) Forecast, by End User, 2022-2032
Table 21: Latin America Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 22: Latin America Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 23: Latin America Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 24: Latin America Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 25: Latin America Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
Table 26: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 27: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Product Type, 2022-2032
Table 28: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Application, 2022-2032
Table 29: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Disease Screening, 2022-2032
Table 30: Middle East & Africa Market Revenue (US$ Mn) Forecast, by End-user, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Size (US$ Mn) Forecast, 2022-2032
Figure 02: Global Market Value Share, by Region (2018)
Figure 04: Global Market Value Share, by Application (2018)
Figure 03: Global Market Value Share, by Product Type (2018)
Figure 05: Global Market Value Share, by End-user (2018)
Figure 06: Global Market Value Share, by Product Type, 2022 and 2032
Figure 07: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2022-2032
Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Kits & Reagents,
Figure 09: Global Market Attractiveness, by Product Type, 2022-2032
Figure 10: Global Market Value Share, by Application, 2022 and 2032
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Grouping, 2022-2032
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Screening,
Figure 13: Global Market Attractiveness, by Application, 2022-2032
Figure 14: Global Market Value Share, by End-user, 2022 and 2032
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2022-2032
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Banks,
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2022-2032
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Plasma Fractionation Companies, 2022-2032
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2022-2032
Figure 20: Global Market Attractiveness, by End-user, 2022-2032
Figure 21: Global Market Value Share, by Region, 2022 and 2032
Figure 22: Global Market Attractiveness, by Region, 2022-2032
Figure 23: North America Market Value Share, by Country, 2022 and 2032
Figure 24: North America Market Attractiveness, by Country, 2022-2032
Figure 25: North America Market Value Share, by Product Type, 2022 and 2032
Figure 26: North America Market Attractiveness, by Product Type, 2022-2032
Figure 27: North America Market Value Share, by Application, 2022 and 2032
Figure 28: North America Market Attractiveness, by Application, 2022-2032
Figure 29: North America Market Value Share, by End-user, 2022 and 2032
Figure 30: North America Market Attractiveness, by End-user, 2022-2032
Figure 31: Europe Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 32: Europe Market Attractiveness, by Country/Sub-region, 2022-2032
Figure 33: Europe Market Value Share, by Product Type, 2022 and 2032
Figure 34: Europe Market Attractiveness, by Product Type, 2022-2032
Figure 35: Europe Market Value Share, by Application, 2022 and 2032
Figure 36: Europe Market Attractiveness, by Application, 2022-2032
Figure 37: Europe Market Value Share, by End-user, 2022 and 2032
Figure 38: Europe Market Attractiveness, by End-user, 2022-2032
Figure 39: Asia Pacific Market Value Share, by Country/Sub-region, 2022 and 2032
Figure 40: Asia Pacific Market Attractiveness, by Country/Sub-region, 2022-2032
Figure 41: Asia Pacific Market Value Share, by Product Type, 2022 and 2032
Figure 42: Asia Pacific Market Attractiveness, by Product Type, 2022-2032
Figure 43: Asia Pacific Market Value Share, by Application, 2022 and 2032
Figure 44: Asia Pacific Market Attractiveness, by Application, 2022-2032
Figure 45: Asia Pacific Market Value Share, by End-user, 2022 and 2032
Figure 46: Asia Pacific Market Attractiveness, by End-user, 2022-2032
Figure 47: Latin America Market Value Share, by Country/Sub-region, 2020 and 2025
Figure 48: Latin America Market Attractiveness, by Country/Sub-Region, 2022-2032
Figure 49: Latin America Market Value Share, by Product Type, 2022 and 2032
Figure 50: Latin America Market Attractiveness, by Product Type, 2022-2032
Figure 51: Latin America Market Value Share, by Application, 2022 and 2032
Figure 52: Latin America Market Attractiveness, by Application, 2022-2032
Figure 53: Latin America Market Value Share, by End-user, 2022 and 2032
Figure 54: Latin America Market Attractiveness, by End-user, 2022-2032
Figure 55: Middle East & Africa Market Value Share, by Country/Sub-Region, 2022 and 2032
Figure 56: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2022-2032
Figure 57: Middle East & Africa Market Value Share, by Product Type, 2022 and 2032
Figure 58: Middle East & Africa Market Attractiveness, by Product Type, 2022-2032
Figure 59: Middle East & Africa Market Value Share, by Application, 2022 and 2032
Figure 60: Middle East & Africa Market Attractiveness, by Application, 2022-2032
Figure 61: Middle East & Africa Market Value Share, by End-user, 2022 and 2032
Figure 62: Middle East & Africa Market Attractiveness, by End-user, 2022-2032
Figure 63: Global Market Share (%) & Market Share Range (%), by Company, 2020 (Estimated)
Figure 64: Grifols S.A. Breakdown of Net Sales, by Business Segment, 2020
Figure 65: Grifols S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 66: DiaSorin S.p.A. Breakdown of Net Sales, by Region, 2020
Figure 67: DiaSorin S.p.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 68: Immucor, Inc., Breakdown of Net Sales, by Product Group, 2021
Figure 69: Immucor, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 70: Abbott Breakdown of Revenue (US$ Mn), by Region, 2021
Figure 71: Abbott Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021
Figure 72: Bio-Rad Laboratories, Inc., Breakdown of Net Sales, by Region, 2021
Figure 73: Bio-Rad Laboratories, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021
Figure 74: Hologic, Inc., Breakdown of Net Sales, by Region, 2021
Figure 75: Hologic, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 76: QUOTIENT LIMITED, Breakdown of Net Sales, by Product Group, 2021
Figure 77: QUOTIENT LIMITED, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Figure 78: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Business Segment, 2021
Figure 79: F. Hoffmann-La Roche Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the market worth for Blood Transfusion Diagnostic in 2021?
As of 2021, the Blood Transfusion Diagnostic market was worth US$ 4.42 Billion.
At what value is the Blood Transfusion Diagnostic industry likely to close by 2022?
Fact.MR foresees Blood Transfusion Diagnostic demand to reach US$ 4.73 Billion in 2022.
At what percentage will the market for Blood Transfusion Diagnostic rise until 2032?
From 2022-2032, Fact.MR expects Blood Transfusion Diagnostic revenue to flourish at a 7% CAGR.
What is the expected market value for Blood Transfusion Diagnostic in 2032?
In 2032, Blood Transfusion Diagnostic market worth is poised to reach US$ 8.7 Billion.
How do growth prospects for Blood Transfusion Diagnostic appear in the North America?
North American regional market is expected to rise at a cagr of 6.4%.
How do growth prospects for Blood Transfusion Diagnostic appear in the Asia Pacific?
The Asia Pacific is expected to possess 7% market cagr for Blood Transfusion Diagnostic in 2032.
Which type of product is expected to hold the maximum share for Blood Transfusion Diagnostic market?
The kits & reagents Blood Transfusion Diagnostic segment is expected to hold the maximum share.
Which type of application is expected to hold the maximum share for Blood Transfusion Diagnostic market?
Blood grouping segment is expected to possess maximum market share for Blood Transfusion Diagnostic.
Blood Transfusion Diagnostics Market